curriculum vitae - University Institute of Immunology - UniversitÃ¤t Bern

More documents

Recommendations

Info

C.V.: Beda M. Stadler page 42A-140.A-141.A-142.A-143.A-144.A-145.A-146.A-147.A-148.A-149.A-150.A-151.A-152.A-153.A-154.A-155.A-156.A-157.A-158.A-159.A-160.A-161.A-162.A-163.A-164.Furukawa, K, de Weck, A.L. and Stadler, B.M. Anti-IgE antibodies modify IgE. binding to FcRI. XVthEuropean Congress of Allergology and Clinical Immunology. Paris. 1992.de Weck, A.L. Furukawa, K, Urwyler, A., Stadler, B.M. Dahinden, C.A., and Maly, F.E. Sulfidoleukotriene-ELISA: A new cellular approach to the diagnostic of allergies. XVth European Congress of Allergology andClinical Immunology. Paris. 1992.Rudolf, M.P., Vogel, M., Stadler, B.M. Generation of a random epitope library of IgE. V. Meeting of theSwiss Immunology Ph.D. Students. Wolfsberg. 1993Stämpfli, M.R., Aebischer, I., Miescher, S., and Stadler, B.M. Anti-IgE monoclonal antibodies modulatehuman IgE synthesis. V. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1993Kägi, M., Vogel, M., Miescher, S., Wüthrich, B., and Stadler, B.M. High levels of CH3 domain specific anti-IgE antibodies in atopic patients. American Academy of Allergy and Immunology. 1993.de Weck, A.L., Stadler, B.M., Bühlmann, R.P., Wehner, H.-U., and Urwyler, A. A new Sulfidoleukotrieneassayfor the detection and monitoring of allergies and pseudoallergies. American Academy of Allergy andImmunology. 1993.Hüppi, P., Amato, M., Ramseyer, V. and Stadler, B.M. Specific serum antibodies against curosurf. 8th Int.Workshop on Surfactant Replacement. Oslo, Norway, 1993Luger, T., Aebischer, I. and Stadler, B.M. Regulation of IgE Production and Interferon gamma synthesis byProopiomelanocortin derived peptides. The European Society for Dermatological Research. 1993Aebischer, I., Zürcher, A., Stämpfli, M.R. and Stadler, B.M. Neuroendocrine peptides modulate human IgEsynthesis. Annual Meeting of the European Academy of Allergology and Clinical Immunology.Rotterdam. 1993.Stämpfli, M.R. Aebischer, I., Miescher, S., de Weck, A.L. and Stadler, B.M. Domain specific modulation ofIgE synthesis by monoclonal anti-IgE antibodies. Annual Meeting of the European Academy ofAllergology and Clinical Immunology. Rotterdam. 1993.Stadler, B.M. Autoimmune and Neuroendocrine Regulation of the Allergic Response, Hand out: speciallecture, Basic Clinical Allergy Course, London, 1993Stadler, B.M. Die Rolle von Anti-IgE Autoantikörper, Hand out: FMH Kurs der Schweiz. Ges. fürAllergologie und Immunologie, Genf, 1993Miescher, S., Vogel., M., Biaggi, C., and Stadler, B.M. Production of recombinant anti-IgE antibodies. Annualmeeting SGAI/SSAI. Geneva. 1993.de Weck, A.L., Stadler, B.M., Müller, U., Jutel, M., Urwyler, A., and Vassella, C. The CAST: a new dimensionin Allergy research. American Academy of Allergy and Immunology. 1994.Vogel., M., Lang, A., Miescher, S., and Stadler, B.M. Utilization of phage display libraries for the production ofhuman antibodies. Annual meeting SGAI/SSAI. Basel. 1994.Stämpfli, M.R. Aebischer, I., Miescher, S., Zürcher, A. and Stadler, B.M. Mechanism of IgE synthesisinhibition by anti-IgE antibodies. SGAI/SSAI. Basel. 1994.Zürcher, A., Lang, A. Aebischer, I., Miescher, S., and Stadler, B.M. Lack of specific B cell hybridomageneration after culture in the CD40 system. VI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1994.Stämpfli, M.R. Aebischer, I., Miescher, S., Zürcher, A. and Stadler, B.M. Different mechanism of IgEsynthesis inhibition by anti-IgE antibodies. VI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1994.Zürcher, A., Lang, A. Aebischer, I., Miescher, S., and Stadler, B.M. IL-4 and CD40 antibody do not promoteexpansion of allergen-specific B cells SGAI/SSAI. Basel. 1994.Stadler, B.M. Neuroendocrine and Autoimmune Regulation of the Allergic Response, FERAI Meeting,Lausanne, 1994Vogel., M., Miescher, S., Biaggi, C., and Stadler, B.M. Production of human anti-IgE antibodies. KeystoneMeeting. T24: antibody engineering.1994.Rudolf, M.P., Vogel, M., and Stadler, B.M. Generation of a random epitope library and expression of IgEdomains. VI. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg. 1994.Stadler, B.M., Vogel, M., Rudolf, M.P., Lilin Lai Zhang and Miescher, S., From recombinant to syntheticmimotopes, European Peptide Society Meeting, Interlaken, Switzerland. 1995Vogel, M., Miescher, S., Biaggi, C. and Stadler, B.M. Cloning of anti-IgE antibodies: anti-idiotypes versusanti-isotypes, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Miescher, S., Vogel, M., Aeby, P., Brick, B., Biaggi, C. Rudolf, M.and Stadler, B.M. Isolation of human anti-Rhesus D, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995
C.V.: Beda M. Stadler page 43A-165.A-166.A-167.A-168.A-169.A-170.A-171.A-172.A-173.A-174.A-175.A-176.A-177.A-178.A-179.A-180.A-181.A-182.A-183.A-184.A-185.A-186.Rudolf, M.. Vogel, M., Miescher, S., Kocher. H., Kricek, F.and Stadler, B.M. Inhibition of IgE binding to FcRIwithout affecting the binding site, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Biaggi, C. Vogel, M., Lang, A., Miescher, S. and Stadler, B.M. Recombinant anti-tetanus antibodies fortherapy, SGAI/SSAI Meeting, Lausanne-CHUV, Switzerland. 1995Zürcher, A., and Stadler, B.M. B cell cultures from the nouse, SGAI/SSAI Meeting, Lausanne-CHUV,Switzerland. 1995Rudolf, M.. Furukawa, K., Vogel, M., Miescher, S.and Stadler, B.M. Binding of IgE / anti-IgE Immunecomplexes to the high affinity receptor FcRI. Meeting of the Swiss Immunology Ph.D. Students.Wolfsberg. 1995Jawien, J., Szczeklik, A., and Stadler, B.M. Human anti-IgE autoantibodies follow the rise of serumimmunglobulin E levels in response to tissue injury. Meeting of the European Society for ClinicalInvestigation. Interlaken, Switzerland, 24-27 April. 1996Horn, M.P., Biaggi, C., Miescher, S., Vogel. M., Rudolf, M.P. and Stadler, B.M. Molecular basis of crossreactive antibodies. VII. Meeting of the Swiss Immunology Ph.D. Students. Wolfsberg, Switzerland, 20-22March, 1996.Zürcher, M.P., Zürcher, A.W., Rudolf, M.P., Lang, A.B., Stadler, B.M. Protective tetanus toxoid epitopes.SGAI Meeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Vogel, M., Lai, L. Curcio-Vonlanthen, R.V., Miescher, S., and Stadler, B.M. Cross reactive anti-tetanus andanti-melittin Fab fragments by phage display after tetanus toxoid immunization. SGAI Meeting 1996. St.Gallen, Switzerland, 11.-14. April. 1996.Horn, M.P., Miescher, S., Vogel, M., Rudolf, M.P., Biaggi, C., and Stadler, B.M. Cross reactive antibodiesagainst tetanus toxoid and the human high-affinity receptor for IgE by phage display. SGAI Meeting 1996. St.Gallen, Switzerland, 11.-14. April. 1996.Rudolf. M.P., Kricek, F., Vogel, M., Miescher, S., and Stadler, B.M. Derivation of a vaccine for atopy based onmimotopes. SGAI Meeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Zürcher, A.W., Derer, T., Lang, A.B., and Stadler, B.M. Culture and IgE synthesis of nasal B cells. SGAIMeeting 1996. St. Gallen, Switzerland, 11.-14. April. 1996.Rudolf, M.P., Kricek, F., Vogel, M., Miescher, S., Stadler, B.M. Specific anti-human IgE response bymimotope immunization. New York Academy of Sciences: B Cells and Autoimmunity Meeting. Prague,Czech Republique, 21-25. Mai 1996.Horn, M.P., Miescher, S., Vogel, M., Rudolf, M.P., Biaggi, C., and Stadler, B.M. Isolation of cross reactingantibodies against tetanus toxoid and the human high-affinity receptor for IgE, an autoantigen ofpathphysiological importance. New York Academy of Sciences: B Cells and Autoimmunity Meeting.Prague, Czech Republique, 21-25. Mai 1996.Stadler, B.M., Rudolf, M.P., Zürcher, A.W., Horn, M., Miescher, S., Vogel, M., and Kricek, F. Can activeImmunization redirect an anti-IgE autoimmune response?. Collegium Internationale Allergologicum.Fuschl, Austria 6-11. Sept. 1996.A. Huber, D. Genser, S. Spitzauer, D. Kraft, C. Ebner, B. Stadler and E. Jensen-Jarolim. Does food-specificIgE play a role in Crohn’s disease? Annual Meeting ÖGAI. Vienna, Austria. 1996.Stadler, B.M. Gene therapy in the general context of gene technology. Swiss Tissue Culture SocietyWorkshop „Gene therapy", Egerkingen, Oct. 30., 1996Zürcher, A.W., Rudolf, M.P., Vogel, M., Stadler, B.M. Mimotope-based anti-IgE peptide and DNA vaccines.SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 74.1997Zimmermann, R., Finger, A., Hohenfeld, U., Klima, I., Gautschi, E., Thalmann, G., Cecchini, M.G., Stdler,B.M, Studer, U., Miescher, S., Ball, R. Gene therapy of prostatic cancer by targeting tumour blood vessels.SGAI/SSAI Meeting 1997, Zürich.Vogel, M.,Miescher,S., Rudolf, M., Stadler, B.M. Evidence of idiotype conservation in mice and men.SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 90. 1997Horn, M.P., Krebs, S., Vogel, M., Miescher, S., Stadler, B.M. Appearance of cross reactive antibodies againstthe FcRI- chain after tetanus toxoid vaccination. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 93.1997.Zürcher, M.P., Zürcher, A.W., Rudolf, M.P., Vogel, M., Lang, A.B., Stadler, B.M. Protective tetanus toxoidepitopes. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 91. 1997.Finger, A., Zimmermann, R., Hohenfeld, U., Klima, I., Gautschi, E., Thalmann, G., Cecchini, M.G., Stadler,B.M, Studer, U., Miescher, S., Ball, R. Gene therapy of prostatic carcinoma by targeting tumour bloodvessels. SGAI/SSAI Meeting, Zürich. Allergologie 20: (2) 93. 1997.
Page 1 and 2: CURRICULUM VITAENameBeda Martin STA
Page 3 and 4: C.V.: Beda M. Stadler page 3EDUCATI
Page 5 and 6: C.V.: Beda M. Stadler page 5Special
Page 7 and 8: C.V.: Beda M. Stadler page 7Societi
Page 9 and 10: C.V.: Beda M. Stadler page 92001 -
Page 11 and 12: C.V.: Beda M. Stadler page 11Editor
Page 13 and 14: C.V.: Beda M. Stadler page 1316. Lu
Page 15: C.V.: Beda M. Stadler page 1553. Br
Page 18 and 19: C.V.: Beda M. Stadler page 18104. S
Page 20 and 21: C.V.: Beda M. Stadler page 20Monogr
Page 22 and 23: C.V.: Beda M. Stadler page 22R-32.R
Page 28 and 29: C.V.: Beda M. Stadler page 28Patent
Page 30 and 31: C.V.: Beda M. Stadler page 30Editor
Page 32 and 33: C.V.: Beda M. Stadler page 32I-40.I
Page 34 and 35: C.V.: Beda M. Stadler page 34I-80.B
Page 36: C.V.: Beda M. Stadler page 36Abstra
Page 39 and 40: C.V.: Beda M. Stadler page 39A-71.A
Page 41: C.V.: Beda M. Stadler page 41A-115.
Page 45 and 46: C.V.: Beda M. Stadler page 45A-209.
Page 47 and 48: C.V.: Beda M. Stadler page 47A-250.

curriculum vitae - University Institute of Immunology - UniversitÃ¤t Bern

Create successful ePaper yourself

Delete template?

Save as template?